Log in
NYSE:PRGO

Perrigo Stock Forecast, Price & News

$43.87
+1.34 (+3.15 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$41.88
Now: $43.87
$43.87
50-Day Range
$42.53
MA: $46.15
$50.14
52-Week Range
$40.01
Now: $43.87
$63.86
Volume1.07 million shs
Average Volume1.02 million shs
Market Capitalization$5.99 billion
P/E Ratio25.21
Dividend Yield2.12%
Beta1.15
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid, 24HR, Good Sense, Zephrex D, ScarAway, Plackers, and Rembrandt. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands and consumer focused products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More
Perrigo logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.71 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000
Employees11,200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.84 billion
Cash Flow$6.65 per share
Book Value$42.64 per share

Profitability

Net Income$146.10 million

Miscellaneous

Market Cap$5.99 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$43.87
+1.34 (+3.15 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Perrigo (NYSE:PRGO) Frequently Asked Questions

How has Perrigo's stock price been impacted by Coronavirus?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRGO shares have decreased by 4.7% and is now trading at $43.87.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Perrigo?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Perrigo
.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Perrigo
.

How can I listen to Perrigo's earnings call?

Perrigo will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) announced its quarterly earnings data on Wednesday, August, 5th. The company reported $1.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.87 by $0.16. The firm had revenue of $1.22 billion for the quarter, compared to analysts' expectations of $1.23 billion. Perrigo had a return on equity of 10.05% and a net margin of 4.73%. The company's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.86 EPS.
View Perrigo's earnings history
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, October 22nd. Investors of record on Friday, November 27th will be paid a dividend of $0.225 per share on Tuesday, December 15th. This represents a $0.90 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend is Wednesday, November 25th.
View Perrigo's dividend history
.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY20 earnings guidance on Thursday, September, 17th. The company provided EPS guidance of $3.95-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.02.

What price target have analysts set for PRGO?

7 Wall Street analysts have issued 12-month target prices for Perrigo's shares. Their forecasts range from $49.00 to $70.00. On average, they anticipate Perrigo's share price to reach $58.33 in the next twelve months. This suggests a possible upside of 33.0% from the stock's current price.
View analysts' price targets for Perrigo
.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 60, Pay $3.06M)
  • Mr. Raymond P. Silcock, CFO, Principal Accounting Officer & Exec. VP (Age 69, Pay $1.48M)
  • Mr. James E. Dillard III, Exec. VP & Chief Scientific Officer (Age 56, Pay $1.01M)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 58, Pay $1.08M)
  • Mr. Ronald C. Janish, Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain (Age 54)

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of institutional and retail investors. Top institutional investors include Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.58%), Harel Insurance Investments & Financial Services Ltd. (0.64%), Manning & Napier Group LLC (0.22%), State of Alaska Department of Revenue (0.08%), State of New Jersey Common Pension Fund D (0.06%) and Standard Life Aberdeen plc (0.05%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo
.

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Franklin Street Advisors Inc. NC, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, Standard Life Aberdeen plc, State of New Jersey Common Pension Fund D, Retirement Systems of Alabama, and Robeco Institutional Asset Management B.V.. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, and Todd W Kingma.
View insider buying and selling activity for Perrigo
.

Which major investors are buying Perrigo stock?

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, Alaska Permanent Fund Corp, American Assets Investment Management LLC, Forsta AP Fonden, Wedge Capital Management L L P NC, Envestnet Asset Management Inc., and Avantax Advisory Services Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Murray S Kessler, Svend Andersen, Theodore R Samuels II, and Todd W Kingma.
View insider buying and selling activity for Perrigo
.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $43.87.

How big of a company is Perrigo?

Perrigo has a market capitalization of $5.99 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.